Adipotide is a targeted peptide that acts specifically on adipose tissue vasculature, distinct from general weight‑loss compounds. It selectively targets blood vessels supplying fat cells, inducing apoptosis in adipocytes and reducing fat mass through a unique vascular‑mediated mechanism. By disrupting blood flow to adipose tissue, it promotes targeted fat reduction without widespread systemic effects on metabolism or appetite. Its tissue‑specific mode of action offers a focused approach to obesity research, differing from traditional GLP‑1 agonists and appetite suppressants.
